Company profile

Prospection


Expertise: Marketing, Data science & analytics



Bio: We are a leading health insights company with commercial, technical and clinical capabilities. Our unique cross functional approach allows us to understand our client’s problems then design and deliver outstanding solutions.

We work with over 50 healthcare clients to provide quality and innovative solutions. Our clients encompass a broad range of healthcare organisations including government and agencies, pharma and device manufacturers, hospitals, researchers and clinicians, patient and disease support organisations.

Our solutions encompass consulting, data analytics and technology platforms. We work with our clients closely and we seek to add value through collaboration, deep insights and the innovative use of data.

​We offer rich technical and data analytical capabilities through our platforms PharmDash and PharmMap. Our consulting footprint spans across all stages of the product lifecycle including pre-launch, market access, brand strategy and commercial effectiveness.
[Total: 1    Average: 5/5]

News & Trends - Medical Technology

MedTech News - Technology levels up support for healthcare employees - Matt Moran, MD, Philips

Technology levels up support for healthcare employees – Matt Moran, MD, Philips

Health Industry Hub | January 22, 2021 |

MedTech News: Matt Moran, Managing Director of Philips Australia & New Zealad, reflects on the impact of the COVID-19 pandemic […]

More


Medical

Aussie researchers receive $2.9m funding boost for multiple sclerosis

Health Industry Hub | January 22, 2021 |

Medical News: Twenty multiple sclerosis (MS) scientific research teams across the country will receive an important New Year funding injection […]

More


News & Trends - Biotechnology

Biotech News - AusBiotech renews agreements with international stakeholders

AusBiotech renews agreements with international stakeholders

Health Industry Hub | January 22, 2021 |

Biotech News: AusBiotech’s international partnerships have been extended, with new Memorandums of Understanding (MoU) signed with major international industry associations […]

More


News & Trends - Pharmaceuticals

Pharma News - AbbVie's phase 3 wins for Humira successor Skyrizi

AbbVie’s phase 3 wins for Humira successor Skyrizi

Health Industry Hub | January 22, 2021 |

Pharma News: AbbVie is in a race against time as patent expiry of its Humira inflammatory diseases blockbuster draws near […]

More